Modulation of kainate-induced responses by pentobarbitone and GYKI- 53784 in rat abducens motoneurons in vivo

Brain Research

Volumn 818, Issue 2, 1999, Pages 421-430

  Ruiz, Arnaud ^a   Durand, Jacques ^a  

^a U de Neurocybernetique Cell   (France)

Author keywords

2,3 Benzodiazepine; AMPA; Barbiturate anesthesia; Excitatory amino acid; Kainate; Ketamine

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; KAINIC ACID; KAINIC ACID RECEPTOR; KETAMINE; PENTOBARBITAL; UNCLASSIFIED DRUG;

ABDUCENS NERVE; ADOLESCENT; ANESTHESIA; ANTIDROMIC STIMULATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOTONEURON; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ABDUCENS NERVE; ANIMALS; BENZODIAZEPINES; EXCITATORY AMINO ACID ANTAGONISTS; GABA MODULATORS; KAINIC ACID; MEMBRANE POTENTIALS; MOTOR NEURONS; PENTOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 0033550694     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01335-3     Document Type: Article

References (45)

1. Barker J.L., Ransom B.R. Pentobarbitone pharmacology of mammalian central neurons grown in tissue culture. J. Physiol. (London). 280:1978;355-372.
2. Bleakman D., Ballyk B.A., Schoepp D.D., Palmer A.J., Bath C.P., Sharpe E.F., Woolley M.L., Bufton H.R., Kamboj R.K., Tarnawa I., Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology. 35:1996;1689-1702.
3. Castillo P.E., Malenka R.C., Nicoll R.A. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature. 388:1997;182-186.
4. Dildy-Mayfield J.E., Eger E.I. II, Harris R.A. Anesthetics produce subunit-selective actions on glutamate receptors. J. Pharmacol. Exp. Ther. 276:1996;1058-1065.
5. Donevan S.D., Rogawski M.A. GYKI-52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
6. Durand J. Electrophysiological and morphological properties of rat abducens motoneurons. Exp. Brain Res. 76:1989;141-152.
7. Durand J. NMDA actions on rat abducens motoneurons. Eur. J. Neurosci. 3:1991;621-633.
8. Durand J. Synaptic excitation triggers oscillations during NMDA receptor activation in rat abducens motoneurons. Eur. J. Neurosci. 5:1993;1389-1397.
9. Durand J., Ruiz A., Carnino A. Discrimination in vivo between AMPA- and kainate-induced responses in abducens motoneurons with pentobarbitone and 2,3-benzodiazepines. Soc. Neurosci. Abstr. 23:1997;1201.
10. Engberg I., Tarnawa I., Durand J., Ouardouz M. An analysis of synaptic transmission to motoneurons in the cat spinal cord using a new selective receptor blocker. Acta Physiol. Scand. 148:1993;97-100.
11. Franks N.P., Lieb W.R. Molecular and cellular mechanisms of general anesthesia. Nature. 367:1994;607-614.
12. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 11:1990;205-211.
13. Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., Seeburg P.H. The KA-2 subunit of excitatory amino acid receptors shows wide spread expression in brain and forms ion channels with distantly related subunits. Neuron. 8:1992;775-785.
14. Johansen T.H., Chaudhary A., Verdoorn T.A. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48:1995;946-955.
15. Lambert J.D.C., Flatman J. The interaction between barbiturate anaesthetics and excitatory amino acid responses on cat spinal neurons. Neuropharmacology. 20:1981;227-240.
16. Lodge D., Bond A., O'Neill M.K., Hicks C.A., Jones M. Stereoselective effects of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology. 35:1996;1681-1688.
17. MacDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino-acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
18. Marszalec W., Naharashi T. Use-dependent block of kainate and quisqualate currents. Brain Res. 608:1993;7-15.
19. Miljkovic Z., MacDonald J.F. Voltage-dependent block of excitatory amino acid currents by pentobarbital. Brain Res. 376:1986;396-399.
20. Minami K., Wick M.J., Stern-Bach Y., Dildy-Mayfield J.E., Brozowski S.J., Gonzales E.L., Trudell J.R., Harris R.A. Sites of volatile anesthetic action on kainate (glutamate receptor 6) receptors. J. Biol. Chem. 273:1998;8248-8255.
21. Nakanishi S., Nakajima Y., Masu M., Yoshiki U., Nakahara K., Watanabe D., Yamaguchi S., Kawabata S., Okada M. Glutamate receptors: brain function and signal transduction. Brain Res. Rev. 26:1998;230-235.
22. Ouardouz M., Durand J. GYKI-52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurons. Neurosci. Lett. 125:1991;5-8.
23. Ouardouz M., Durand J. Involvement of AMPA receptors in trigeminal postsynaptic potentials recorded in rat abducens motoneurons in vivo. Eur. J. Neurosci. 6:1994;1662-1668.
24. Parker I., Gundersen C.B., Miledi R. Actions of pentobarbital on rat brain receptors expressed in Xenopus oocytes. J. Neurosci. 6:1986;2290-2297.
25. Partin K.M., Mayer M.L. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI-53655. Mol. Pharmacol. 49:1996;142-148.
26. Paternain A.V., Morales M., Lerma J. Selective antagonism of AMPA receptor-mediated responses in hippocampal neurons. Neuron. 14:1995;185-189.
27. Rammes G., Swandulla D., Collingridge G.L., Hartmann S., Parsons C.G. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors - Patch-clamp recordings in cultured neurons and area CA1 in hippocampal slices. Br. J. Pharmacol. 117:1996;1209-1221.
28. Renard A., Crepel F., Audinat E. Evidence for two types of non-NMDA receptors in rat cerebellar purkinje cells maintained in slices cultures. Neuropharmacology. 34:1995;335-346.
29. Ruiz A., Durand J. GYKI-53655 but not NBQX discriminates AMPA- and kainate-induced responses in rat abducens motoneurons in vivo. Eur. J. Neurosci. 9:1996;8. suppl.
30. A. Ruiz, J. Durand, Blocking the trigeminal EPSPs in rat abducens motoneurons in vivo with the AMPA antagonists, NBQX and GYKI-53655, J. Neurophysiol. (1998) submitted.
31. Sawada S., Yamamoto C. Blocking action of pentobarbital on receptors for excitatory amino acids in the guinea pig hippocampus. Exp. Brain Res. 59:1987;226-231.
32. I. Tarnawa, I. Engberg, J. Flatman, GYKI-52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist, in: G. Lubec, G.A. Rosenthal (Eds.), Amino acids: Chemistry, Biology and Medicine, Escom Science Publishers, Leiden, 1990, pp. 538-546.
33. Tarnawa I., Berzsenyi P., Andrasi F., Botka P., Hamori T., Ling I., Körösi J. Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action. Bioorg. Med. Chem. Lett. 3:1993;99-104.
34. Taverna F.A., Cameron B.R., Hampson D.L., Wang L.Y., MacDonald J.F. Sensitivity of AMPA receptors to pentobarbital. Eur. J. Pharmacol. 267:1994;3-5.
35. Vignes M., Collingridge G.L. The synaptic activation of kainate receptors. Nature. 388:1997;179-182.
36. Vizi E.S., Mike A., Tarnawa I. 2,3-Benzodiazepines (GYKI-52466 and analogs). Negative allosteric modulators of AMPA receptors. C.N.S. Drug Rev. 2:1996;91-126.
37. J.C. Watkins, G.L. Collingridge (Eds.), The NMDA Receptor, IRL Press, Oxford Univ. Press, 1989, 242 pp.
38. H. Wheal, A.M. Thomson (Eds.), Excitatory Amino Acids and Synaptic Transmission, Academic Press, 2nd edn., Harcourt Brace Publishers, London, 1995, 388 pp.
39. Wilding T.J., Huettner J.E. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors. Mol. Pharmacol. 49:1996;540-546.
40. Wilding T.J., Huettner J.E. Activation and desensitization of hippocampal kainate receptors. J. Neurosci. 17:1997;2713-2721.
41. Yamada K.A., Turetsky D.M. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists. Br. J. Pharmacol. 117:1996;1663-1672.
42. Yamakura T., Sakimura K., Mishina M., Shimoji K. The sensitivity of AMPA-selective glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the α2 subunit. FEBS Lett. 374:1995;412-414.
43. Yamamoto C., Sawada S., Ohno-Shosaku T. Distribution and properties of kainate receptors distinct in the CA3 region of the hippocampus of the guinea pig. Brain Res. 783:1998;227-235.
44. Zeman S., Lodge D. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Br. J. Pharmacol. 106:1992;367-372.
45. Zorumski C.F., Yamada K.A., Price M.T., Olney J.W. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron. 10:1993;61-67.